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###### Key points

For people with dementia, there is a generally linear relationship between those with the least perceived functional impairments and those with the greatest perceived functional impairment and their ability to live well.Even subtle difficulties in activities of daily living have a detrimental effect on the ability of people with dementia to live well.Depression in people with dementia and carer stress in informants need to be routinely considered in future research studies and clinical assessments.

1. INTRODUCTION {#gps5128-sec-0007}
===============

Dementia refers to a group of progressive brain disorders associated with largely generalised mental functioning difficulties, including memory and other aspects of cognition, behavioural disturbances, and reduced activities of daily living (ADL).[1](#gps5128-bib-0001){ref-type="ref"}, [2](#gps5128-bib-0002){ref-type="ref"} Impairment in ADL is diagnostically central to dementia.[3](#gps5128-bib-0003){ref-type="ref"}, [4](#gps5128-bib-0004){ref-type="ref"} There is a hierarchical sequence of decline in ADL that distinguishes between basic ADL and instrumental ADL.[5](#gps5128-bib-0005){ref-type="ref"} In early‐stage dementia, basic ADL, such as bathing, eating, and dressing, show little decline,[6](#gps5128-bib-0006){ref-type="ref"} whereas instrumental ADL, such as using a telephone, managing finances, and managing medication, show noticeable decline,[7](#gps5128-bib-0007){ref-type="ref"}, [8](#gps5128-bib-0008){ref-type="ref"} and evidence suggests linkage between declining instrumental ADL and cognitive abilities.[9](#gps5128-bib-0009){ref-type="ref"}, [10](#gps5128-bib-0010){ref-type="ref"} This evidence led to the dependence framework, conceptualised as the measurable impact that concomitant cognitive and functional difficulties and increased neuropsychiatric symptoms exert as dementia severity increases.[11](#gps5128-bib-0011){ref-type="ref"}

The dependence framework and the "disablement process" theory propose that increased dependence negatively affects quality of life (QoL).[11](#gps5128-bib-0011){ref-type="ref"}, [12](#gps5128-bib-0012){ref-type="ref"} People with dementia identify functional independence as an important factor in enhancing their QoL.[13](#gps5128-bib-0013){ref-type="ref"}, [14](#gps5128-bib-0014){ref-type="ref"}, [15](#gps5128-bib-0015){ref-type="ref"} In the United Kingdom, the Alzheimer\'s Society identifies improving the QoL of people with dementia by promoting functional ability and independence as one of its five priority goals for dementia care research.[16](#gps5128-bib-0016){ref-type="ref"} Recent dementia policy has prioritised enabling people to "live well" with dementia by improving health care and the quality of support offered to people with dementia.[17](#gps5128-bib-0017){ref-type="ref"}, [18](#gps5128-bib-0018){ref-type="ref"}

A primary goal for dementia care is to maximise the ability to live well with the condition.[19](#gps5128-bib-0019){ref-type="ref"} Living well in people living with chronic illness and disability is defined as the best achievable health state that encompasses all dimensions of physical, mental, and social well‐being.[20](#gps5128-bib-0020){ref-type="ref"}, [21](#gps5128-bib-0021){ref-type="ref"}, [22](#gps5128-bib-0022){ref-type="ref"} While the concept of QoL concerns integration of interpersonal and health factors, as indicated above, the well‐being concept can be considered as a state of equilibrium or balance, which is affected by life events or challenges,[23](#gps5128-bib-0023){ref-type="ref"} while satisfaction with life entails a global evaluation of one\'s current life.[24](#gps5128-bib-0024){ref-type="ref"} Integration of these three concepts captures a more complete understanding of what it is to live well with a particular condition.[22](#gps5128-bib-0022){ref-type="ref"}, [25](#gps5128-bib-0025){ref-type="ref"}, [26](#gps5128-bib-0026){ref-type="ref"} Understanding the relationship between functional ability and subjective perceptions of living well is important, particularly as no preventive or curative treatment for dementia is currently available.

In people with dementia, reduced functional ability is consistently associated with higher depression, increased age, lower education, and poorer cognitive status.[2](#gps5128-bib-0002){ref-type="ref"}, [11](#gps5128-bib-0011){ref-type="ref"}, [27](#gps5128-bib-0027){ref-type="ref"}, [28](#gps5128-bib-0028){ref-type="ref"}, [29](#gps5128-bib-0029){ref-type="ref"}, [30](#gps5128-bib-0030){ref-type="ref"}, [31](#gps5128-bib-0031){ref-type="ref"}, [32](#gps5128-bib-0032){ref-type="ref"} Functional ability has also been investigated concerning self‐rated and informant‐rated QoL in dementia, with functional difficulties leading to poorer QoL outcomes.[33](#gps5128-bib-0033){ref-type="ref"}, [34](#gps5128-bib-0034){ref-type="ref"}, [35](#gps5128-bib-0035){ref-type="ref"}, [36](#gps5128-bib-0036){ref-type="ref"}, [37](#gps5128-bib-0037){ref-type="ref"}, [38](#gps5128-bib-0038){ref-type="ref"}, [39](#gps5128-bib-0039){ref-type="ref"} Investigating QoL in people with mild‐to‐moderate dementia typically involves use of either self‐ratings or informant ratings,[40](#gps5128-bib-0040){ref-type="ref"} and it is generally accepted that people with mild‐to‐moderate dementia can provide valid self‐ratings.[39](#gps5128-bib-0039){ref-type="ref"} In contrast, for assessing functional ability, informant ratings are the primary method of assessment,[2](#gps5128-bib-0002){ref-type="ref"}, [41](#gps5128-bib-0041){ref-type="ref"} often assumed to be the more accurate, with cognitive decline precluding the possibility of obtaining valid self‐ratings.[28](#gps5128-bib-0028){ref-type="ref"}, [42](#gps5128-bib-0042){ref-type="ref"}, [43](#gps5128-bib-0043){ref-type="ref"}, [44](#gps5128-bib-0044){ref-type="ref"} However, higher carer stress is consistently associated with lower informant‐rated functional ability[45](#gps5128-bib-0045){ref-type="ref"}, [46](#gps5128-bib-0046){ref-type="ref"} whereas carer stress is typically unrelated to objectively assessed functional performance.[32](#gps5128-bib-0032){ref-type="ref"}, [46](#gps5128-bib-0046){ref-type="ref"} We recently found that, when comparing self‐ratings and informant ratings of functional ability with objective performance, people with mild‐to‐moderate dementia were able to more accurately appraise their functional ability than their informants, with the latter typically underestimating ability.[32](#gps5128-bib-0032){ref-type="ref"} In view of this finding, it is important to consider how subjective perceptions of functional ability relate to both self‐rated and informant‐rated living well scores.

In summary, it is timely to investigate how different levels of functional ability relate to living well in people with mild‐to‐moderate dementia, as this could influence the type of care and support required and the timing of appropriate interventions. The present study has two aims. Firstly, since there is evidence that people with mild‐to‐moderate dementia can provide accurate self‐ratings of functional ability, we consider how different levels of self‐rated ability and informant‐rated ability relate to three indicators of living well: perceptions of QoL, satisfaction with life, and well‐being. Secondly, we aim to identify whether the level of functional ability across the spectrum of impairment affects subjective perceptions of living well, controlling for relevant variables including depression, cognition, and carer stress.

2. METHODS {#gps5128-sec-0008}
==========

2.1. Design {#gps5128-sec-0009}
-----------

The Improving the experience of Dementia and Enhancing Active Life (IDEAL) programme is a 9‐year longitudinal cohort study investigating influences on living well with dementia.[25](#gps5128-bib-0025){ref-type="ref"}, [26](#gps5128-bib-0026){ref-type="ref"} This paper presents cross‐sectional data from version 2.0 of the IDEAL dataset for initial assessments conducted between July 2014 and August 2016. The cohort at baseline included 1547 participants with dementia together with 1283 informants, mostly spouses/partners. Only those with complete data for the Functional Activities Questionnaire (FAQ)[30](#gps5128-bib-0030){ref-type="ref"}, [47](#gps5128-bib-0047){ref-type="ref"} were included in the present analysis, yielding a sample of 1493 people with dementia and 1188 informants. Participants were recruited through UK National Health Service research networks across England, Scotland, and Wales. To be included, participants had to have a clinical diagnosis of dementia as judged by clinicians at recruitment sites and a score of 15 or above on the Mini‐Mental State Examination,[48](#gps5128-bib-0048){ref-type="ref"} indicating mild‐to‐moderate dementia, and the ability to communicate verbally in English. Exclusion criteria were comorbid terminal illness, inability to provide informed consent, and any known potential for home visits to pose a significant risk to researchers. Informants were recruited into the study if they were willing to take part and were proving regular care to the person with dementia.[49](#gps5128-bib-0049){ref-type="ref"} Full criteria for exclusion and consent are provided in the protocol.[25](#gps5128-bib-0025){ref-type="ref"} The IDEAL study was approved by the Wales Research Ethics Committee 5 (reference 13/WA/0405) and the Ethics Committee of the School of Psychology, Bangor University (reference 2014‐11684), and is registered with UKCRN, registration number 16593.

2.2. Measures {#gps5128-sec-0010}
-------------

### 2.2.1. Functional ability {#gps5128-sec-0011}

To measure instrumental ADL, we employed an 11‐item FAQ, modified from the original 10 items to include a question concerning telephone use.[30](#gps5128-bib-0030){ref-type="ref"} Each item was rated on a 0 to 3 scale leading to a score range of 0 to 33; a higher score indicated greater perceived difficulty with functional ability. Both self‐rated (FAQ‐S) and informant‐rated (FAQ‐I) versions were used in the study. FAQ scores were split into six levels of impairment. Level 1 comprised those with no reported functional impairment (FAQ 0). To indicate impairment, a cut‐off score of 5 has been proposed.[47](#gps5128-bib-0047){ref-type="ref"} We have previously found that this cut‐off is commensurate with the amended FAQ scoring, and in our previous study, no one was reclassified as impaired using the self‐rated or informant‐rated amended FAQ.[30](#gps5128-bib-0030){ref-type="ref"} Therefore, level 2 included those who scored 1 to 5. An alternative FAQ cut‐off score of 9 has been recommended as indicative of impairment[44](#gps5128-bib-0044){ref-type="ref"} and is used primarily in North America;[50](#gps5128-bib-0050){ref-type="ref"} thus, level 3 included those who scored 6 to 9. The remaining three groups reflect equal score ranges comprising 8 points each: level 4 (10‐17), level 5 (18‐25), and level 6 (26‐33). Participants with dementia who had no informant participating in the study were included in the analyses using FAQ‐S ratings but not in the analyses using FAQ‐I ratings.

### 2.2.2. Living well {#gps5128-sec-0012}

We used three measures to assess living well with dementia. These were the QoL in Alzheimer\'s Disease scale score (QoL‐AD),[51](#gps5128-bib-0051){ref-type="ref"} Satisfaction with Life Scale score (SwLS),[52](#gps5128-bib-0052){ref-type="ref"} and the World Health Organization‐Five Well‐being Index (WHO‐5)[53](#gps5128-bib-0053){ref-type="ref"}, [54](#gps5128-bib-0054){ref-type="ref"} percentage score. For each measure, a higher score indicates greater capability to live well: QoL‐AD range 13 to 52, SwLS range 5 to 35, and WHO‐5 range 0 to 100. Both self‐rated and informant‐rated versions of each measure were used. For convenience, the three measures together will be referred to as "living well measures."

### 2.2.3. Cognition, mood, and carer stress {#gps5128-sec-0013}

The following additional measures from the IDEAL dataset were included in this analysis. The Addenbrooke\'s Cognitive Examination‐III (ACE‐III)[55](#gps5128-bib-0055){ref-type="ref"} was used to measure cognition in participants with dementia. The ACE‐III is scored out of 100 with higher scores indicating better cognitive functioning. The Geriatric Depression Scale‐10 (GDS‐10)[56](#gps5128-bib-0056){ref-type="ref"} was used to measure depression in participants with dementia, with higher scores indicating more self‐rated depressive symptoms. For the purposes of the analysis, the sample was split into two groups: not depressed (GDS‐10 = 0‐3) and depressed (GDS‐10 = 4‐10). The Relatives\' Stress Scale (RSS)[57](#gps5128-bib-0057){ref-type="ref"} measured the level of self‐reported carer stress; possible scores range from 0 to 60 with higher scores indicating greater carer stress.

### 2.2.4. Sociodemographic and diagnostic variables {#gps5128-sec-0014}

For the participants with dementia, we obtained information about age, gender, education, diagnosis, and relationship to the informant. Participants were classified into five groups based on age (younger than 65, 65‐69, 70‐74, 75‐79, and 80 years and older) and education (no qualifications, school leaving certificate at age 16, school leaving certificate at age 18, and university). Relationship to the informant was classified into three groups (spouse/partner, other, and no informant participating).

2.3. Procedure {#gps5128-sec-0015}
--------------

Information was collected from people with dementia and informants who were visited at home by a researcher on three occasions spread over a few weeks. Informed consent was obtained from both the person with dementia and the informant (where available).

2.4. Planned analyses {#gps5128-sec-0016}
---------------------

A series of multivariate multiple regression analyses examined the relationship between the six FAQ impairment levels and scores on the living well measures, with separate analyses conducted for self‐ratings by the person with dementia and informant ratings. As the group with FAQ scores between 10 and 17 contained the second largest number of responses for both self‐rated and informant‐rated FAQ, it was used as the reference group in the regression analyses. Self‐rated living well measures were included in the self‐rated FAQ regression model, and informant‐rated living well measures were included in the informant‐rated FAQ model. For the first research aim, regression analyses were used to examine the unadjusted association between FAQ scores and living well measures for both self‐rated and informant‐rated scores. Further analyses were conducted adjusting for known covariates such as age, sex, education, and diagnosis. Further adjustments added ACE‐III and depression in the person with dementia (GDS‐10) to the model. A fifth model was tested with informant‐rated FAQ scores only, adding carer stress (RSS) to the model. Preprocessing of data included checking for normalised data assumptions for both individual measures and combined scores. All assumptions were met at each stage.

For the second research aim, as the three living well measures employed different scoring systems, scores were standardised. Multivariate multiple regression models for each rating type were repeated using the standardised scores so that the living well measures could be directly compared.

Multiple imputation was conducted to account for missing data. Ordinal variables were imputed using ordinal regression, and categorical variables were imputed using multinomial regression. The imputed model included all variables in the analysis. Estimates from 10 imputed datasets were combined using Rubin\'s rules.[58](#gps5128-bib-0058){ref-type="ref"}

3. RESULTS {#gps5128-sec-0017}
==========

The 1493 participants with dementia were in the mild‐to‐moderate stages. There were more men than women with dementia, and Alzheimer\'s disease was the most frequent diagnosis (Table [1](#gps5128-tbl-0001){ref-type="table"}). The 1188 informants were mostly spouses, and there were more female than male informants. RSS scores indicate relatively mild levels of carer stress. Means for the three living well measures indicate that people with dementia rate their ability to live well more positively than informants; see Table [S1](#gps5128-supitem-0001){ref-type="supplementary-material"} for mean and percentage data. The inclusion of the additional telephone use item in the amended version of the FAQ had little effect on the number of people classified as impaired; for self‐rated and informant‐rated FAQ, there were, respectively, five (0.3%) and six (0.5%) additional participants classified as impaired following inclusion of the additional item. There were slightly more classified as impaired with the amended FAQ using the cut‐off score of 9 with 22 (1.5%) and 17 (1.4%) for self‐rated and informant‐rated FAQ, respectively.

###### 

Self‐ and informant‐rated functional ability across sociodemographic, diagnostic, and depression groups

                                             n (%)         FAQ‐S Mean (SD)   n (%)        FAQ‐I Mean (SD)
  ------------------------------------------ ------------- ----------------- ------------ -----------------
  Diagnosis                                                                               
  Alzheimer\'s disease                       829 (55.5)    8.82 (7.36)       664 (55.9)   17.30 (8.35)
  Vascular dementia                          161 (10.8)    10.83 (8.21)      127 (10.7)   17.82 (8.43)
  Mixed Alzheimer\'s and vascular dementia   317 (21.2)    9.73 (7.81)       242 (20.4)   18.00 (9.22)
  Frontotemporal dementia                    52 (3.5)      8.60 (7.02)       44 (3.7)     17.68 (9.43)
  Parkinson\'s disease dementia              42 (2.8)      13.12 (7.94)      40 (3.4)     19.83 (8.27)
  Dementia with Lewy bodies                  51 (3.4)      14.59 (7.43)      41 (3.5)     22.00 (6.79)
  Unspecified dementia/other                 41 (2.7)      10.39 (8.59)      30 (2.5)     20.57 (9.52)
  Education                                                                               
  No qualifications                          406 (27.2)    10.64 (7.56)      304 (25.6)   17.71 (8.28)
  School leaving certificate at age 16       257 (17.2)    9.79 (7.78)       211 (17.8)   18.33 (8.42)
  School leaving certificate at age 18       503 (33.7)    9.25 (7.77)       410 (34.5)   17.90 (8.80)
  University                                 295 (19.8)    8.47 (7.50)       234 (19.7)   17.24 (8.91)
  Missing                                    32 (2.1)                        29 (2.4)     
  Gender                                                                                  
  Male                                       849 (56.9)    9.65 (7.90)       703 (59.2)   17.87 (8.74)
  Female                                     644 (43.1)    9.50 (7.41)       485 (40.8)   17.80 (8.41)
  Age group, y                                                                            
  \<65                                       133 (8.9)     11.96 (8.05)      97 (8.2)     17.44 (8.71)
  65‐69                                      175 (11.7)    9.07 (7.46)       148 (12.5)   16.45 (8.70)
  70‐74                                      253 (16.9)    8.72 (7.90)       212 (17.8)   16.31 (8.73)
  75‐79                                      352 (23.6)    9.34 (7.21)       279 (23.5)   18.07 (8.60)
  80+                                        580 (38.8)    9.73 (7.78)       452 (38.0)   18.96 (8.36)
  Informant relationship                                                                  
  Spouse/partner                             1011 (67.7)   9.86 (7.81)       965 (81.2)   17.55 (8.59)
  Other                                      231 (15.5)    10.63 (8.13)      223 (18.8)   19.09 (8.58)
  No informant participating                 251 (16.8)    7.53 (6.34)                    N/A
  Mood                                                                                    
  Depressed (GDS‐10 4‐10)                    435 (29.1)    12.45 (7.96)      344 (29.0)   19.09 (8.59)
  Not depressed (GDS‐10 0‐3)                 1017 (68.1)   8.30 (7.15)       815 (68.6)   17.23 (8.55)
  Missing                                    41 (2.7)                        29 (2.4)     
  Functional ability level                                                                
  FAQ 0 level 1                              136 (9.1)                       31 (2.6)     
  FAQ 1‐5 level 2                            423 (28.3)                      92 (7.7)     
  FAQ 6‐9 level 3                            287 (19.2)                      100 (8.4)    
  FAQ 10‐17 level 4                          397 (26.6)                      329 (27.7)   
  FAQ 18‐25 level 5                          188 (12.6)                      382 (32.2)   
  FAQ 26‐33 level 6                          62 (4.2)                        254 (21.4)   

Abbreviations: FAQ, Functional Activities Questionnaire; FAQ‐I, informant‐rated FAQ; FAQ‐S, self‐rated FAQ; GDS‐10, Geriatric Depression Scale‐10.

3.1. Self‐rated functional ability and living well measures {#gps5128-sec-0018}
-----------------------------------------------------------

Table [2](#gps5128-tbl-0002){ref-type="table"} reports unadjusted and adjusted coefficients between the six FAQ‐S levels and the self‐rated living well measures. Those whose self‐ratings placed them in the most functionally impaired group had lower QoL‐AD, SwLS, and WHO‐5 scores compared with those in the least functionally impaired group. Coefficients reduced after adjusting for sociodemographic and diagnostic factors and slightly increased after further adjustment for ACE‐III score. The largest reduction in coefficients was after adjusting for GDS‐10 score. Figure [1](#gps5128-fig-0001){ref-type="fig"} shows standardised scores for self‐rated living well measures by FAQ‐S level adjusting for sociodemographic and diagnostic factors, ACE‐III, and GDS‐10. For FAQ‐S, coefficients showed a similar declining pattern for QoL‐AD and WHO‐5, indicating that these measures had a similar relationship with functional ability irrespective of FAQ level. SwLS showed the least change across functional ability level with coefficients around zero, though across all FAQ levels, confidence intervals overlapped; see Table [S2](#gps5128-supitem-0001){ref-type="supplementary-material"}.

###### 

Relationship of self‐rated functional ability to scores on living well measures: Unadjusted and adjusted unstandardised regression coefficients and 95% confidence intervals

                                                                                                                                                 QoL‐AD                                                           SwLS                                                               WHO‐5
  -------------------------------------------------------------------------- ------------------------------------------------------------------- ---------------------------------------------------------------- ------------------------------------------------------------------ -------------------------------------------------------------------
  Model 1 Unadjusted                                                         FAQ‐S 0                                                             4.67 (3.56 to 5.78)[\*\*\*](#gps5128-note-0005){ref-type="fn"}   2.76 (1.58 to 3.93)[\*\*\*](#gps5128-note-0005){ref-type="fn"}     13.55 (9.64 to 17.45)[\*\*\*](#gps5128-note-0005){ref-type="fn"}
  FAQ‐S 1‐5                                                                  1.84 (1.06 to 2.62)[\*\*\*](#gps5128-note-0005){ref-type="fn"}      1.00 (0.18 to 1.82)[\*](#gps5128-note-0003){ref-type="fn"}       5.79 (3.04 to 8.53)[\*\*\*](#gps5128-note-0005){ref-type="fn"}     
  FAQ‐S 6‐9                                                                  0.87 (0.01 to 1.73)                                                 0.53 (−0.38 to 1.44)                                             3.65 (0.60 to 6.70)[\*](#gps5128-note-0003){ref-type="fn"}         
  FAQ‐S 10‐17                                                                ref                                                                 ref                                                              ref                                                                
  FAQ‐S 18‐25                                                                −2.36 (−3.35 to −1.38)[\*\*\*](#gps5128-note-0005){ref-type="fn"}   −1.32 (−2.37 to −0.28)[\*](#gps5128-note-0003){ref-type="fn"}    −3.83 (−7.32 to −0.35)[\*](#gps5128-note-0003){ref-type="fn"}      
  FAQ‐S 26‐33                                                                −2.29 (−3.81 to −0.77)[\*\*](#gps5128-note-0004){ref-type="fn"}     −0.94 (−2.55 to 0.67)                                            −5.10 (−10.47 to 0.28)                                             
  Model 2 Adjusted for age, sex, diagnosis, and education                    FAQ‐S 0                                                             4.31 (3.21 to 5.41)[\*\*\*](#gps5128-note-0005){ref-type="fn"}   2.30 (1.13 to 3.46)[\*\*\*](#gps5128-note-0005){ref-type="fn"}     12.30 (8.40 to 16.20)[\*\*\*](#gps5128-note-0005){ref-type="fn"}
  FAQ‐S 1‐5                                                                  1.50 (0.73 to 2.27)[\*\*\*](#gps5128-note-0005){ref-type="fn"}      0.58 (−0.24 to 1.39)                                             4.65 (1.91 to 7.39)[\*\*\*](#gps5128-note-0005){ref-type="fn"}     
  FAQ‐S 6‐9                                                                  0.71 (−0.14 to 1.56)                                                0.26 (−0.64 to 1.15)                                             2.93 (−0.09 to 5.95)                                               
  FAQ‐S 10‐17                                                                ref                                                                 ref                                                              ref                                                                
  FAQ‐S 18‐25                                                                −2.03 (−3.00 to −1.06)[\*\*\*](#gps5128-note-0005){ref-type="fn"}   −1.09 (−2.12 to −0.06)[\*](#gps5128-note-0003){ref-type="fn"}    −3.17 (−6.61 to 0.28)                                              
  FAQ‐S 26‐33                                                                −1.93 (−3.42 to −0.43)[\*](#gps5128-note-0003){ref-type="fn"}       −0.63 (−2.21 to 0.95)                                            −4.40 (−9.71 to 0.92)                                              
  Model 3 Adjusted for age, sex, diagnosis, education, and ACE‐III           FAQ‐S 0                                                             4.53 (3.42 to 5.65)[\*\*\*](#gps5128-note-0005){ref-type="fn"}   2.59 (1.42 to 3.76)[\*\*\*](#gps5128-note-0005){ref-type="fn"}     14.20 (10.28 to 18.12)[\*\*\*](#gps5128-note-0005){ref-type="fn"}
  FAQ‐S 1‐5                                                                  1.69 (0.90 to 2.47)[\*\*\*](#gps5128-note-0005){ref-type="fn"}      0.82 (−0.00 to 1.65)                                             6.24 (3.46 to 9.01)[\*\*\*](#gps5128-note-0005){ref-type="fn"}     
  FAQ‐S 6‐9                                                                  0.80 (−0.05 to 1.66)                                                0.39 (−0.51 to 1.28)                                             3.75 (0.74 to 6.75)[\*\*](#gps5128-note-0004){ref-type="fn"}       
  FAQ‐S 10‐17                                                                ref                                                                 ref                                                              ref                                                                
  FAQ‐S 18‐25                                                                −2.25 (−3.24 to −1.26)[\*\*\*](#gps5128-note-0005){ref-type="fn"}   −1.38 (−2.42 to −0.33)[\*](#gps5128-note-0003){ref-type="fn"}    −5.00 (−8.48 to −1.53)[\*\*](#gps5128-note-0004){ref-type="fn"}    
  FAQ‐S 26‐33                                                                −2.28 (−3.81 to −0.76)[\*\*](#gps5128-note-0004){ref-type="fn"}     −1.10 (−2.71 to 0.51)                                            −7.41 (−12.81 to −2.01)[\*\*](#gps5128-note-0004){ref-type="fn"}   
  Model 4 Adjusted for age, sex, diagnosis, education, ACE‐III, and GDS‐10   FAQ‐S 0                                                             2.79 (1.83 to 3.74)[\*\*\*](#gps5128-note-0005){ref-type="fn"}   1.08 (0.02 to 2.15)[\*](#gps5128-note-0003){ref-type="fn"}         8.54 (5.07 to 12.01)[\*\*\*](#gps5128-note-0005){ref-type="fn"}
  FAQ‐S 1‐5                                                                  0.80 (0.13 to 1.47)[\*](#gps5128-note-0003){ref-type="fn"}          0.05 (−0.70 to 0.81)                                             3.36 (0.92 to 5.80)[\*\*](#gps5128-note-0004){ref-type="fn"}       
  FAQ‐S 6‐9                                                                  0.14 (−0.59 to 0.87)                                                −0.19 (−1.00 to 0.62)                                            1.59 (−1.05 to 4.23)                                               
  FAQ‐S 10‐17                                                                ref                                                                 ref                                                              ref                                                                
  FAQ‐S 18‐25                                                                −1.22 (−2.07 to −0.37)[\*\*](#gps5128-note-0004){ref-type="fn"}     −0.48 (−1.43 to 0.46)                                            −1.66 (−4.73 to 1.42)                                              
  FAQ‐S 26‐33                                                                −1.39 (−2.69 to −0.08)[\*](#gps5128-note-0003){ref-type="fn"}       −0.32 (−1.78 to 1.13)                                            −4.50 (−9.22 to 0.22)                                              

Abbreviations: ACE‐III, Addenbrooke\'s Cognitive Examination‐III; FAQ‐S, self‐rated Functional Activities Questionnaire; GDS‐10, Geriatric Depression Scale‐10; QoL‐AD, Quality of Life in Alzheimer\'s Disease; SwLS, Satisfaction with Life Scale; WHO‐5, World Health Organization‐Five Well‐being Index.

*P* ≤ .05.

*P* ≤ .01.

*P* ≤ .001.

![Self‐rated functional ability level by standardised scores on self‐rated living well measures. FAQ, Functional Activities Questionnaire; QoL‐AD, Quality of Life in Alzheimer\'s Disease; SwLS, Satisfaction with Life Scale; WHO‐5, World Health Organization‐Five Well‐being Index \[Colour figure can be viewed at [wileyonlinelibrary.com](http://wileyonlinelibrary.com)\]](GPS-34-1251-g001){#gps5128-fig-0001}

3.2. Informant‐rated functional ability and living well measures {#gps5128-sec-0019}
----------------------------------------------------------------

Table [3](#gps5128-tbl-0003){ref-type="table"} reports the unadjusted and adjusted coefficients between the six FAQ‐I levels and the informant‐rated living well measures. Compared with those with the least informant‐rated functional impairment, those in the most functionally impaired group had lower QoL‐AD, SwLS, and WHO‐5 scores. After adjusting for sociodemographic and diagnostic factors, the differences were largely unchanged. Coefficients increased slightly after further adjustment for ACE‐III score, while adjusting for GDS‐10 score produced a slight reduction. Adjusting for RSS score produced the largest reduction in coefficients. Figure [2](#gps5128-fig-0002){ref-type="fig"} shows standardised informant‐rated living well measures by FAQ‐I level adjusting for sociodemographic and diagnostic factors, ACE‐III, GDS‐10, and RSS. For FAQ‐I, QoL‐AD showed the biggest difference between the most and least functionally impaired participants. The direction of coefficients was similar for all three living well measures, although across all FAQ levels, confidence intervals overlapped; see Table [S3](#gps5128-supitem-0001){ref-type="supplementary-material"}.

###### 

Relationship of informant‐rated functional ability to scores on living well measures: Unadjusted and adjusted unstandardised regression coefficients and 95% confidence intervals

                                                                                                                                                      QoL‐AD                                                              SwLS                                                                   WHO‐5
  ------------------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- ---------------------------------------------------------------------- ------------------------------------------------------------------
  Model 1 Unadjusted                                                              FAQ‐I 0                                                             6.82 (4.92 to 8.73)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      5.75 (3.30 to 8.20)[\*\*\*](#gps5128-note-0009){ref-type="fn"}         15.56 (8.61 to 22.51)[\*\*\*](#gps5128-note-0009){ref-type="fn"}
  FAQ‐I 1‐5                                                                       4.42 (3.23 to 5.62)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      2.76 (1.22 to 4.30)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      12.48 (8.11 to 16.84)[\*\*\*](#gps5128-note-0009){ref-type="fn"}       
  FAQ‐I 6‐9                                                                       2.62 (1.46 to 3.78)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      1.37 (−0.12 to 2.86)                                                7.63 (3.41 to 11.86)[\*\*\*](#gps5128-note-0009){ref-type="fn"}        
  FAQ‐I 10‐17                                                                     ref                                                                 ref                                                                 ref                                                                    
  FAQ‐I 18‐25                                                                     −2.38 (−3.14 to −1.61)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −1.66 (−2.64 to −0.68)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −7.70 (−10.48 to −4.91)[\*\*\*](#gps5128-note-0009){ref-type="fn"}     
  FAQ‐I 26‐33                                                                     −4.28 (−5.13 to −3.44)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −3.38 (−4.47 to −2.28)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −12.98 (−16.07 to −9.88)[\*\*\*](#gps5128-note-0009){ref-type="fn"}    
  Model 2 Adjusted for age, sex, diagnosis, and education                         FAQ‐I 0                                                             6.80 (4.89 to 8.72)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      6.20 (3.79 to 8.60)[\*\*\*](#gps5128-note-0009){ref-type="fn"}         15.41 (8.47 to 22.35)[\*\*\*](#gps5128-note-0009){ref-type="fn"}
  FAQ‐I 1‐5                                                                       4.36 (3.16 to 5.56)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      2.66 (1.14 to 4.17)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      12.10 (7.74 to 16.46)[\*\*\*](#gps5128-note-0009){ref-type="fn"}       
  FAQ‐I 6‐9                                                                       2.60 (1.44 to 3.76)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      1.23 (−0.23 to 2.69)                                                7.52 (3.31 to 11.73)[\*\*\*](#gps5128-note-0009){ref-type="fn"}        
  FAQ‐I 10‐17                                                                     ref                                                                 ref                                                                 ref                                                                    
  FAQ‐I 18‐25                                                                     −2.40 (−3.16 to −1.63)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −1.75 (−2.72 to −0.78)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −7.58 (−10.36 to −4.79)[\*\*\*](#gps5128-note-0009){ref-type="fn"}     
  FAQ‐I 26‐33                                                                     −4.17 (−5.02 to −3.31)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −3.33 (−4.42 to −2.25)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −12.25 (−15.36 to −9.15)[\*\*\*](#gps5128-note-0009){ref-type="fn"}    
  Model 3 Adjusted for age, sex, diagnosis, education, and ACE‐III                FAQ‐I 0                                                             7.03 (5.11 to 8.96)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      6.52 (4.10 to 8.95)[\*\*\*](#gps5128-note-0009){ref-type="fn"}         16.63 (9.66 to 23.60)[\*\*\*](#gps5128-note-0009){ref-type="fn"}
  FAQ‐I 1‐5                                                                       4.49 (3.28 to 5.70)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      2.84 (1.31 to 4.36)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      12.78 (8.41 to 17.16)[\*\*\*](#gps5128-note-0009){ref-type="fn"}       
  FAQ‐I 6‐9                                                                       2.68 (1.51 to 3.84)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      1.34 (−0.12 to 2.80)                                                7.94 (3.73 to 12.14)[\*\*\*](#gps5128-note-0009){ref-type="fn"}        
  FAQ‐I 10‐17                                                                     ref                                                                 ref                                                                 ref                                                                    
  FAQ‐I 18‐25                                                                     −2.51 (−3.29 to −1.74)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −1.91 (−2.89 to −0.94)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −8.19 (−11.00 to −5.38)[\*\*\*](#gps5128-note-0009){ref-type="fn"}     
  FAQ‐I 26‐33                                                                     −4.51 (−5.43 to −3.59)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −3.83 (−5.00 to −2.66)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −14.10 (−17.44 to −10.75)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   
  Model 4 Adjusted for age, sex, diagnosis, education, ACE‐III, and GDS‐10        FAQ‐I 0                                                             6.93 (5.09 to 8.77)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      6.41 (4.07 to 8.74)[\*\*\*](#gps5128-note-0009){ref-type="fn"}         16.23 (9.65 to 22.81)[\*\*\*](#gps5128-note-0009){ref-type="fn"}
  FAQ‐I 1‐5                                                                       4.34 (3.18 to 5.49)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      2.65 (1.19 to 4.12)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      12.14 (8.02 to 16.27)[\*\*\*](#gps5128-note-0009){ref-type="fn"}       
  FAQ‐I 6‐9                                                                       2.56 (1.45 to 3.67)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      1.20 (−0.20 to 2.61)                                                7.46 (3.49 to 11.42)[\*\*\*](#gps5128-note-0009){ref-type="fn"}        
  FAQ‐I 10‐17                                                                     ref                                                                 ref                                                                 ref                                                                    
  FAQ‐I 18‐25                                                                     −2.44 (−3.18 to −1.70)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −1.83 (−2.77 to −0.89)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −7.90 (−10.56 to −5.25)[\*\*\*](#gps5128-note-0009){ref-type="fn"}     
  FAQ‐I 26‐33                                                                     −4.30 (−5.18 to −3.42)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −3.58 (−4.71 to −2.45)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −13.24 (−16.40 to −10.08)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   
  Model 5 Adjusted for age, sex, diagnosis, education, ACE‐III, GDS‐10, and RSS   FAQ‐I 0                                                             4.69 (2.99 to 6.40)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      4.54 (2.25 to 6.82)[\*\*\*](#gps5128-note-0009){ref-type="fn"}         9.60 (3.30 to 15.90)[\*\*](#gps5128-note-0008){ref-type="fn"}
  FAQ‐I 1‐5                                                                       2.57 (1.48 to 3.65)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      1.18 (−0.27 to 2.63)                                                6.91 (2.93 to 10.88)[\*\*\*](#gps5128-note-0009){ref-type="fn"}        
  FAQ‐I 6‐9                                                                       1.78 (0.76 to 2.80)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      0.55 (−0.82 to 1.92)                                                5.14 (1.39 to 8.89)[\*\*](#gps5128-note-0008){ref-type="fn"}           
  FAQ‐I 10‐17                                                                     ref                                                                 ref                                                                 ref                                                                    
  FAQ‐I 18‐25                                                                     −1.46 (−2.14 to −0.77)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −1.01 (−1.93 to −0.09)[\*](#gps5128-note-0007){ref-type="fn"}       −4.99 (−7.53 to −2.45)[\*\*\*](#gps5128-note-0009){ref-type="fn"}      
  FAQ‐I 26‐33                                                                     −2.50 (−3.34 to −1.66)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −2.08 (−3.21 to −0.95)[\*\*\*](#gps5128-note-0009){ref-type="fn"}   −7.91 (−11.01 to −4.81)[\*\*\*](#gps5128-note-0009){ref-type="fn"}     

Abbreviations: ACE‐III, Addenbrooke\'s Cognitive Examination‐III; FAQ‐I, informant‐rated Functional Activities Questionnaire; GDS‐10, Geriatric Depression Scale‐10; QoL‐AD, Quality of Life in Alzheimer\'s Disease; RSS, Relatives\' Stress Scale; SwLS, Satisfaction with Life Scale; WHO‐5, World Health Organization‐Five Well‐being Index.

*P* ≤ .05.

*P* ≤ .01.

*P* ≤ .001.

![Informant‐rated functional ability level by standardised scores on informant‐rated living well measures. FAQ, Functional Activities Questionnaire; QoL‐AD, Quality of Life in Alzheimer\'s Disease; SwLS, Satisfaction with Life Scale; WHO‐5, World Health Organization‐Five Well‐being Index](GPS-34-1251-g002){#gps5128-fig-0002}

3.3. Impact of missing data on the results {#gps5128-sec-0020}
------------------------------------------

The percentage of missing data was between 1.3% and 10.5% across all domains for people with dementia and between 0.2% and 6.8% for informants (see Table [S1](#gps5128-supitem-0001){ref-type="supplementary-material"}). Coefficients were generally similar to the complete case analysis, but standard errors reduced after multiple imputations. Imputation did not alter the relationships but improved the precision of estimates.

4. DISCUSSION {#gps5128-sec-0021}
=============

This large cohort study of community‐dwelling people with dementia and their informants across Great Britain investigated the association between perceived functional ability and three measures serving as indices of living well, the QoL‐AD scale, SwLS, and WHO‐5. This study extends previous research, which has primarily focussed only on the association between functional ability and QoL.[25](#gps5128-bib-0025){ref-type="ref"}, [40](#gps5128-bib-0040){ref-type="ref"} The results show a decreasing pattern in living well scores, particularly for QoL and well‐being, from the least to most functionally impaired participants; there was a gradual decline with no clear transition point, and confidence intervals overlapped between the levels. This pattern remained for self‐ratings and informant ratings after correcting for cognition and for sociodemographic and diagnostic factors. Importantly, even subtle perceived functional impairments influenced perceptions of living well. The findings indicate that for self‐ratings and informant ratings, people with dementia with the least functional impairments had greater capability to live well than those with the most functional impairment.

Increased depression in people with dementia attenuated the relationship between self‐rated functional ability and living well measures. Those with higher depression scores reported more impaired functional ability by a difference of four points on self‐rated and two points on informant‐rated functional ability. This may arise because of the potent influence of depression on functional ability and living well. The finding corroborates earlier studies where depression was found to separately influence functional ability and self‐rated indicators of living well.[31](#gps5128-bib-0031){ref-type="ref"}, [33](#gps5128-bib-0033){ref-type="ref"}, [35](#gps5128-bib-0035){ref-type="ref"}, [36](#gps5128-bib-0036){ref-type="ref"}, [39](#gps5128-bib-0039){ref-type="ref"}, [40](#gps5128-bib-0040){ref-type="ref"}, [45](#gps5128-bib-0045){ref-type="ref"}, [59](#gps5128-bib-0059){ref-type="ref"} The majority of previous studies, however, have employed diagnostic classifications or informant ratings of depression. For example, a recent study found that people with dementia who had a formal diagnosis of depression rated themselves as *less* impaired in functional ability than people with dementia who did not have a diagnosis of depression.[28](#gps5128-bib-0028){ref-type="ref"} However, they did not report current levels of depression, so it is possible that ameliorative treatment may have influenced the results. There has been relatively little research investigating the relationship between self‐rated depression and functional ability in people with dementia, primarily because of a scarcity of studies employing self‐rated measures of functional ability.[2](#gps5128-bib-0002){ref-type="ref"} Previously, and consistent with the current findings, we found a significant association between self‐rated depression and self‐rated functional ability,[60](#gps5128-bib-0060){ref-type="ref"} where those who were more depressed rated their functional ability as more impaired. It may be that people who are depressed are likely to overestimate functional impairments because of negative thought processes leading to an overall negative view of self, though in contrast "depressive realism" may lead to a more realistic appraisal.[61](#gps5128-bib-0061){ref-type="ref"} As either interpretation could explain our current findings, further research is needed to clarify how self‐rated depression interacts with self‐rated and objective functional ability in people with dementia to fully delineate the relationship.

Greater carer stress attenuated the associations between informant‐rated functional ability and living well measures. Consistent with previous studies, informants experiencing higher perceived stress tended to rate the person with dementia as having poorer ability to live well and more functional impairment.[40](#gps5128-bib-0040){ref-type="ref"}, [45](#gps5128-bib-0045){ref-type="ref"}, [46](#gps5128-bib-0046){ref-type="ref"}, [62](#gps5128-bib-0062){ref-type="ref"}, [63](#gps5128-bib-0063){ref-type="ref"}, [64](#gps5128-bib-0064){ref-type="ref"}, [65](#gps5128-bib-0065){ref-type="ref"} Interestingly, informants had relatively mild levels of perceived stress, suggesting that even mild carer stress may influence informant ratings of functional ability and living well. This raises questions about the reliability and validity of relying solely on informants to provide judgements of functional ability, particularly as most carers report some level of stress due to their caring responsibilities,[66](#gps5128-bib-0066){ref-type="ref"}, [67](#gps5128-bib-0067){ref-type="ref"} and informant ratings are generally the only source of information collected in functional evaluations during clinical and research assessments.[2](#gps5128-bib-0002){ref-type="ref"}, [45](#gps5128-bib-0045){ref-type="ref"} Levels of carer stress need to be considered in future research and clinical assessments that employ informant ratings. Our findings indicate that it is necessary to account for the influence of carer stress on judgements of functional ability and living well.

Standardising the scores on living well measures allowed for direct comparison of the impact of functional ability on each measure. While there were differences between the living well measures at each level of informant‐rated functional ability, overall, there was a consistent decline in effect sizes between those with the most and least perceived functional ability. For self‐rated living well, QoL and well‐being declined consistently, while satisfaction with life was generally stable across the functional ability levels, which fits with the suggestion that satisfaction with life may be relatively stable; for example, there is little quantitative difference between the scores of university students and healthy older people.[68](#gps5128-bib-0068){ref-type="ref"} The decreasing pattern in living well scores from the least to most functionally impaired participants supports disablement process theory where increasing disability leads to reduced QoL[12](#gps5128-bib-0012){ref-type="ref"} and is also consistent with the emphasis on depression and functional ability in Lawton\'s dementia‐specific model of QoL.[69](#gps5128-bib-0069){ref-type="ref"} The current study extends this to well‐being, although after controlling for depression, self‐rated satisfaction with life was not affected by changes in functional ability.

The study had some limitations. Despite functional difficulties being required for a diagnosis of dementia, ratings by 136 people with dementia and 31 informants reported no functional impairment. This was unrelated to age or type of dementia as most of those with "no functional impairment" were over 80 and had Alzheimer\'s disease. The FAQ has been described as one of the more sensitive functional questionnaires for people with early‐stage dementia[44](#gps5128-bib-0044){ref-type="ref"}, [70](#gps5128-bib-0070){ref-type="ref"} with studies recommending its use to distinguish mild cognitive decline from dementia.[71](#gps5128-bib-0071){ref-type="ref"}, [72](#gps5128-bib-0072){ref-type="ref"} However, while the brevity of the FAQ ensures suitability for people with dementia, it is likely that important aspects of functional ability have been omitted from the measure, such as those included in the Amsterdam Instrumental Activity of Daily Living Questionnaire;[73](#gps5128-bib-0073){ref-type="ref"}, [74](#gps5128-bib-0074){ref-type="ref"} we previously modified the FAQ to include a question on telephone use.[30](#gps5128-bib-0030){ref-type="ref"} Our findings suggest that for some people with early‐stage dementia, the FAQ may not have adequate sensitivity to identify perceived functional difficulties. The QoL‐AD was used to assess QoL. This measure was designed for people with Alzheimer\'s disease and may not be sensitive to measure QoL in other dementias, though our meta‐analysis found it is used extensively across all dementias.[40](#gps5128-bib-0040){ref-type="ref"} While IDEAL is a large study of people with dementia,[25](#gps5128-bib-0025){ref-type="ref"} the cohort consisted almost exclusively of white British participants, which limits the ability to extrapolate to other cultural or ethnic groups. We used only cross‐sectional data from the IDEAL study; this does not address the relationship of functional ability and living well measures over time or allow prediction of long‐term change in both functional ability and living well. These questions will be addressed once longitudinal data are available.

5. CONCLUSION {#gps5128-sec-0022}
=============

We found evidence that people with dementia who have the least perceived functional impairments report better QoL, satisfaction with life, and well‐being than those with the greatest perceived functional impairment. Perceived difficulties in instrumental ADL had a detrimental effect on the ability of people with dementia to live well even at low levels of functional impairment. The relationship between functional ability and living well was generally linear, indicating that as difficulties with everyday activities increase, the ability to live well decreases. Importantly, the study found that standardising QoL, satisfaction with life, and well‐being scores resulted in effect sizes for each that were equivalent between the three measures. Therefore, functional ability contributes to the ability of people with dementia to live well. Depression in people with dementia and carer stress in informants were confirmed as confounding factors that negatively influenced ratings of functional ability and measures of living well. Depression in people with dementia and carer stress in informants need to be routinely considered in future research studies and clinical assessments to help facilitate accurate judgements of functional ability and living well. Longitudinal studies are needed to elucidate whether the association between functional ability and living well remains as dementia severity increases further.
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